Spinal Cord Stimulation Devices Market By Product, By Indication, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

Description

List of Tables

According to a new report published by Allied Market Research, titled, "Spinal Cord Stimulation Devices Market," The spinal cord stimulation devices market was valued at $2.1 billion in 2022, and is estimated to reach $4.8 billion by 2032, growing at a CAGR of 8.4% from 2023 to 2032.

Spinal Cord Stimulation Devices Market - IMG1

The major factors driving the growth of spinal cord stimulation devices market are increase in number of people suffering from chronic pain conditions, technological advancements in spinal cord stimulation devices, and rise in adoption of spinal cord stimulation devices. Chronic pain can be caused by a variety of conditions, such as failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS), degenerative disc disease (DDD), and diabetic neuropathy. These conditions can be debilitating, affecting a person's quality of life and requiring long-term management. Spinal cord stimulation devices have emerged as an effective treatment option for patients suffering from chronic pain conditions who have not responded to other forms of therapy. In addition, spinal cord stimulation devices work by delivering electrical impulses to the spinal cord, disrupting the transmission of pain signals to the brain.

Further, technological advancements in spinal cord stimulation devices have made the devices smaller, flexible, and more effective. For instance, newer devices use high-frequency stimulation, which can provide pain relief without causing the tingling or prickling sensations associated with traditional low-frequency stimulation. In addition, other advances include the development of rechargeable batteries and wireless devices, which improve patient comfort and convenience. These technological advancements are expected to drive the demand for spinal cord stimulation devices as patients and physicians seek out more effective and user-friendly devices.

Moreover, the world's population is aging rapidly, and this demographic shift is expected to drive the demand for spinal cord stimulation devices. Older adults are more likely to suffer from chronic pain conditions, and as the population ages, the number of people in need of spinal cord stimulation therapy is expected to grow. For instance, according to the U.S. Census Bureau 2022, more than 56 million adults aged 65 and older live in the U.S., accounting for about 16.9% of the nation's population; thus, rise in geriatric population is anticipated to fuel the growth of market.

The spinal cord stimulation devices market is segmented into product, indication, end user, and region. On the basis of product, the market is bifurcated into rechargeable devices and non-rechargeable devices. Depending on indication, it is categorized into failed back surgery syndrome, complex regional pain syndrome, degenerative disc disease, and others. By end user, it is segregated into hospital, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America and Middle East Africa)

Major key players that operate in the global spinal cord stimulation devices market are Medtronic Plc, Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, Beijing PINS Medical Co., Ltd, Saluda Medical Pty Ltd., Nalu Medical, Inc., BIOTRONIK, GIMER MEDICAL, and Teliatry, Inc. The key players have adopted strategies such as acquisition, product launch, product approval, and expansion to expand their product portfolio.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the spinal cord stimulation devices market analysis from 2022 to 2032 to identify the prevailing spinal cord stimulation devices market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the spinal cord stimulation devices market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global spinal cord stimulation devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Indication

Failed back surgery syndrome
Complex regional pain syndrome
Degenerative disc disease
Others

By Product

Rechargeable devices
Non-rechargeable devices

By End User

Hospitals
Ambulatory surgical centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East Africa

Key Market Players:

Boston Scientific Corporation
Beijing PINS Medical Co., Ltd
Medtronic plc
Abbott Laboratories
BIOTRONIK SE & Co. KG
Saluda Medical Pty Ltd.
Nalu Medical, Inc.
GIMER MEDICAL
Teliatry, Inc.
Nevro Corporation

Product Code: A03450

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Increase in prevalence of chronic pain conditions
  - 3.4.1.2. Technological advancements in spinal cord stimulation devices
  - 3.4.1.3. Availability of medical reimbursement schemes

3.4.2. Restraints
- 3.4.2.1. High cost and side effects of spinal cord stimulation devices
- 3.4.2.2. Availability of alternative treatment options for chronic pain

3.4.3. Opportunities
- 3.4.3.1. Growth opportunities in emerging markets

3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Rechargeable devices
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Non-rechargeable devices
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country

CHAPTER 5: SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Failed back surgery syndrome
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Complex regional pain syndrome
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Degenerative disc disease
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Others
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country

CHAPTER 6: SPINAL CORD STIMULATION DEVICES MARKET, BY END USER

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Ambulatory surgical centers
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country

CHAPTER 7: SPINAL CORD STIMULATION DEVICES MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Product
- 7.2.3. Market size and forecast, by Indication
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Key market trends, growth factors and opportunities
  - 7.2.5.1.2. Market size and forecast, by Product
  - 7.2.5.1.3. Market size and forecast, by Indication
  - 7.2.5.1.4. Market size and forecast, by End User
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Key market trends, growth factors and opportunities
  - 7.2.5.2.2. Market size and forecast, by Product
  - 7.2.5.2.3. Market size and forecast, by Indication
  - 7.2.5.2.4. Market size and forecast, by End User
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Key market trends, growth factors and opportunities
  - 7.2.5.3.2. Market size and forecast, by Product
  - 7.2.5.3.3. Market size and forecast, by Indication
  - 7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Product
- 7.3.3. Market size and forecast, by Indication
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Key market trends, growth factors and opportunities
  - 7.3.5.1.2. Market size and forecast, by Product
  - 7.3.5.1.3. Market size and forecast, by Indication
  - 7.3.5.1.4. Market size and forecast, by End User
  - 7.3.5.2. France
  - 7.3.5.2.1. Key market trends, growth factors and opportunities
  - 7.3.5.2.2. Market size and forecast, by Product
  - 7.3.5.2.3. Market size and forecast, by Indication
  - 7.3.5.2.4. Market size and forecast, by End User
  - 7.3.5.3. UK
  - 7.3.5.3.1. Key market trends, growth factors and opportunities
  - 7.3.5.3.2. Market size and forecast, by Product
  - 7.3.5.3.3. Market size and forecast, by Indication
  - 7.3.5.3.4. Market size and forecast, by End User
  - 7.3.5.4. Italy
  - 7.3.5.4.1. Key market trends, growth factors and opportunities
  - 7.3.5.4.2. Market size and forecast, by Product
  - 7.3.5.4.3. Market size and forecast, by Indication
  - 7.3.5.4.4. Market size and forecast, by End User
  - 7.3.5.5. Spain
  - 7.3.5.5.1. Key market trends, growth factors and opportunities
  - 7.3.5.5.2. Market size and forecast, by Product
  - 7.3.5.5.3. Market size and forecast, by Indication
  - 7.3.5.5.4. Market size and forecast, by End User
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Key market trends, growth factors and opportunities
  - 7.3.5.6.2. Market size and forecast, by Product
  - 7.3.5.6.3. Market size and forecast, by Indication
  - 7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Product
- 7.4.3. Market size and forecast, by Indication
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. Japan
  - 7.4.5.1.1. Key market trends, growth factors and opportunities
  - 7.4.5.1.2. Market size and forecast, by Product
  - 7.4.5.1.3. Market size and forecast, by Indication
  - 7.4.5.1.4. Market size and forecast, by End User
  - 7.4.5.2. China
  - 7.4.5.2.1. Key market trends, growth factors and opportunities
  - 7.4.5.2.2. Market size and forecast, by Product
  - 7.4.5.2.3. Market size and forecast, by Indication
  - 7.4.5.2.4. Market size and forecast, by End User
  - 7.4.5.3. India
  - 7.4.5.3.1. Key market trends, growth factors and opportunities
  - 7.4.5.3.2. Market size and forecast, by Product
  - 7.4.5.3.3. Market size and forecast, by Indication
  - 7.4.5.3.4. Market size and forecast, by End User
  - 7.4.5.4. Australia
  - 7.4.5.4.1. Key market trends, growth factors and opportunities
  - 7.4.5.4.2. Market size and forecast, by Product
  - 7.4.5.4.3. Market size and forecast, by Indication
  - 7.4.5.4.4. Market size and forecast, by End User
  - 7.4.5.5. South Korea
  - 7.4.5.5.1. Key market trends, growth factors and opportunities
  - 7.4.5.5.2. Market size and forecast, by Product
  - 7.4.5.5.3. Market size and forecast, by Indication
  - 7.4.5.5.4. Market size and forecast, by End User
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Key market trends, growth factors and opportunities
  - 7.4.5.6.2. Market size and forecast, by Product
  - 7.4.5.6.3. Market size and forecast, by Indication
  - 7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Product
- 7.5.3. Market size and forecast, by Indication
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Latin America
  - 7.5.5.1.1. Key market trends, growth factors and opportunities
  - 7.5.5.1.2. Market size and forecast, by Product
  - 7.5.5.1.3. Market size and forecast, by Indication
  - 7.5.5.1.4. Market size and forecast, by End User
  - 7.5.5.2. Middle East Africa
  - 7.5.5.2.1. Key market trends, growth factors and opportunities
  - 7.5.5.2.2. Market size and forecast, by Product
  - 7.5.5.2.3. Market size and forecast, by Indication
  - 7.5.5.2.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. Boston Scientific Corporation
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.1.7. Key strategic moves and developments
9.2. Medtronic plc
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
9.3. Abbott Laboratories
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.3.7. Key strategic moves and developments
9.4. Nevro Corporation
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.4.7. Key strategic moves and developments
9.5. Beijing PINS Medical Co., Ltd
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
9.6. Saluda Medical Pty Ltd.
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Key strategic moves and developments
9.7. Nalu Medical, Inc.
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
9.8. Teliatry, Inc.
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
9.9. GIMER MEDICAL
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Key strategic moves and developments
9.10. BIOTRONIK SE & Co. KG
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Key strategic moves and developments